Variant report

Variant	nsv1011101
Chromosome Location	chr3:189484-274541
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:312)
CpG islands
(count:1221)
Chromatin interactive
region (count:3)
LncRNA
region (count:20)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:312 , 50 per page) page: 1 2 3 4 5 6 7

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr3:254098-254530	GM12878	blood:	n/a	n/a
2	ATF2	chr3:254017-254518	GM12878	blood:	n/a	n/a
3	BACH1	chr3:238826-240389	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr3:238302-238499	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr3:271174-271333	K562	blood:	n/a	n/a
6	BATF	chr3:254085-254416	GM12878	blood:	n/a	n/a
7	BATF	chr3:259675-259847	GM12878	blood:	n/a	n/a
8	BHLHE40	chr3:260263-260618	GM12878	blood:	n/a	n/a
9	BHLHE40	chr3:260829-261058	GM12878	blood:	n/a	n/a
10	CCNT2	chr3:210502-210583	K562	blood:	n/a	n/a
11	CCNT2	chr3:238979-239034	K562	blood:	n/a	n/a
12	CEBPB	chr3:271018-271333	H1-hESC	embryonic stem cell:	n/a	chr3:271305-271317
13	CEBPB	chr3:242440-242811	HepG2	liver:	n/a	n/a
14	CEBPB	chr3:215234-215549	HepG2	liver:	n/a	chr3:215398-215409 chr3:215397-215410
15	CEBPB	chr3:211035-211283	HepG2	liver:	n/a	n/a
16	CEBPB	chr3:216135-216492	A549	lung:	n/a	chr3:216322-216333 chr3:216301-216314 chr3:216321-216334 chr3:216302-216313
17	CEBPB	chr3:242500-242742	K562	blood:	n/a	n/a
18	CEBPB	chr3:215306-215533	K562	blood:	n/a	chr3:215398-215409 chr3:215397-215410
19	CEBPB	chr3:243976-244300	IMR90	lung:	n/a	chr3:244109-244120
20	CEBPB	chr3:242488-242808	A549	lung:	n/a	n/a
21	CEBPB	chr3:243949-244303	HepG2	liver:	n/a	chr3:244109-244120
22	CEBPB	chr3:219216-219513	HepG2	liver:	n/a	n/a
23	CEBPB	chr3:219203-219482	A549	lung:	n/a	n/a
24	CEBPB	chr3:242447-242817	IMR90	lung:	n/a	n/a
25	CEBPB	chr3:244050-244226	H1-hESC	embryonic stem cell:	n/a	chr3:244109-244120
26	CEBPB	chr3:216151-216444	HepG2	liver:	n/a	chr3:216322-216333 chr3:216301-216314 chr3:216321-216334 chr3:216302-216313
27	CEBPB	chr3:242454-242771	H1-hESC	embryonic stem cell:	n/a	n/a
28	CEBPB	chr3:215340-215517	A549	lung:	n/a	chr3:215398-215409 chr3:215397-215410
29	CEBPB	chr3:216138-216415	Hela-S3	cervix:	n/a	chr3:216322-216333 chr3:216301-216314 chr3:216321-216334 chr3:216302-216313
30	CEBPB	chr3:243974-244307	A549	lung:	n/a	chr3:244109-244120
31	CHD1	chr3:238324-238476	H1-hESC	embryonic stem cell:	n/a	n/a
32	CHD1	chr3:195466-195490	GM12878	blood:	n/a	n/a
33	CHD1	chr3:239219-239240	H1-hESC	embryonic stem cell:	n/a	n/a
34	CHD1	chr3:239582-239589	GM12878	blood:	n/a	n/a
35	CHD2	chr3:238225-238590	GM12878	blood:	n/a	n/a
36	CREB1	chr3:254049-254528	GM12878	blood:	n/a	n/a
37	CTBP2	chr3:238125-240202	H1-hESC	embryonic stem cell:	n/a	n/a
38	CTCF	chr3:197740-197890	GM12878	blood:	n/a	n/a
39	CTCF	chr3:249780-249930	SAEC	small airway:	n/a	n/a
40	CTCF	chr3:197800-197950	HEK293	kidney:	n/a	n/a
41	CTCF	chr3:266691-266735	GM20000	blood:	n/a	n/a
42	CTCF	chr3:197360-197510	K562	blood:	n/a	n/a
43	CTCF	chr3:249740-249890	GM12872	blood:	n/a	n/a
44	CTCF	chr3:237420-237570	GM12867	blood:	n/a	n/a
45	CTCF	chr3:197720-197870	GM12872	blood:	n/a	n/a
46	CTCF	chr3:249660-249810	HRPEpiC	eye:	n/a	n/a
47	CTCF	chr3:249700-249850	GM12868	blood:	n/a	n/a
48	CTCF	chr3:197860-198010	RPTEC	kidney:	n/a	n/a
49	CTCF	chr3:237440-237590	GM12874	blood:	n/a	n/a
50	CTCF	chr3:249747-249910	Medullo	brain:	n/a	n/a

(count:1221 , 50 per page) page: 1 2 3 4 5 6 7 ... 25

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:243996-244046	GM12892	blood:	n/a
2	chr3:243996-244046	GM12892	blood:	n/a
3	chr3:238392-238442	BE2_C	brain:	n/a
4	chr3:238618-238668	HCF	heart:	n/a
5	chr3:238618-238668	T-47D	breast:	n/a
6	chr3:243996-244046	HIPEpiC	eye:	n/a
7	chr3:243996-244046	HMEC	breast:	n/a
8	chr3:238496-238546	HIPEpiC	eye:	n/a
9	chr3:239229-239279	HRPEpiC	eye:	n/a
10	chr3:236078-236128	MCF-7	breast:	n/a
11	chr3:239229-239279	BE2_C	brain:	n/a
12	chr3:238618-238668	HL-60	blood:	n/a
13	chr3:238392-238442	AG04450	lung:	fetal
14	chr3:239733-239783	HPAEpiC	pulmonary alveolar:	n/a
15	chr3:271185-271235	H1-hESC	embryonic stem cell:	embryo
16	chr3:240139-240189	MCF-7	breast:	n/a
17	chr3:240139-240189	HPAEpiC	pulmonary alveolar:	n/a
18	chr3:271185-271235	HCM	heart:	n/a
19	chr3:238392-238442	HAEpiC	amniotic membrane:	n/a
20	chr3:238048-238098	HEK293	kidney:	embryo
21	chr3:239188-239238	AG04450	lung:	fetal
22	chr3:240139-240189	HRCEpiC	kidney:	n/a
23	chr3:238392-238442	AG04449	skin:	fetal
24	chr3:239665-239715	MCF10A-Er-Src	breast:	n/a
25	chr3:241182-241232	AG09309	skin:	n/a
26	chr3:238161-238211	SKMC	muscle:	n/a
27	chr3:239188-239238	LNCaP	prostate:	n/a
28	chr3:238618-238668	HEEpiC	esophagus:	n/a
29	chr3:239506-239556	LNCaP	prostate:	n/a
30	chr3:240139-240189	IMR90	lung:	fetal
31	chr3:238318-238368	A549	lung:	n/a
32	chr3:239665-239715	HIPEpiC	eye:	n/a
33	chr3:238618-238668	AoSMC	blood vessel:	n/a
34	chr3:238392-238442	HRCEpiC	kidney:	n/a
35	chr3:238615-238665	AG09319	gingival:	n/a
36	chr3:239733-239783	U87	brain:	n/a
37	chr3:239506-239556	HMEC	breast:	n/a
38	chr3:241182-241232	HCPEpiC	choroid plexus:	n/a
39	chr3:241182-241232	Hepatocyte	liver:	n/a
40	chr3:239229-239279	NHBE	bronchial:	n/a
41	chr3:236078-236128	AG09309	skin:	n/a
42	chr3:239229-239279	GM12892	blood:	n/a
43	chr3:239733-239783	PANC-1	pancreas:	n/a
44	chr3:271185-271235	A549	lung:	n/a
45	chr3:238618-238668	AG09319	gingival:	n/a
46	chr3:239188-239238	GM06990	blood:	n/a
47	chr3:238048-238098	AG09309	skin:	n/a
48	chr3:239229-239279	HepG2	liver:	n/a
49	chr3:238611-238661	GM12878	blood:	n/a
50	chr3:238161-238211	HRPEpiC	eye:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:188824..190368-chr3:386265..388997,2	MCF-7	breast:
2	chr3:217250..219144-chr3:222760..225297,2	MCF-7	breast:
3	chr3:217250..219144-chr3:222760..225297,2	MCF-7	breast:

(count:20 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CNTN6-7	chr3:254887-255362	NONHSAT087562
2	lnc-IL5RA-6	chr3:238650-238882	ENSG00000224318.1
3	lnc-IL5RA-6	chr3:237679-237723	ENSG00000224318.1
4	lnc-CNTN6-7	chr3:239697-239775	NONHSAT087562
5	lnc-IL5RA-6	chr3:237540-237597	NONHSAT087559
6	lnc-IL5RA-6	chr3:238290-238385	ENSG00000224318.1
7	lnc-IL5RA-6	chr3:238290-238542	ENSG00000224318.1
8	lnc-IL5RA-6	chr3:238139-238191	ENSG00000224318.1
9	lnc-IL5RA-6	chr3:238139-238191	ENSG00000224318.1
10	lnc-IL5RA-6	chr3:237679-237723	ENSG00000224318.1
11	lnc-IL5RA-6	chr3:237679-237723	NONHSAT087559
12	lnc-IL5RA-6	chr3:238139-238191	ENSG00000224318.1
13	lnc-IL5RA-6	chr3:237441-237597	ENSG00000224318.1
14	lnc-IL5RA-6	chr3:238650-239024	ENSG00000224318.1
15	lnc-IL5RA-6	chr3:237441-237597	ENSG00000224318.1
16	lnc-IL5RA-6	chr3:237679-237723	ENSG00000224318.1
17	lnc-IL5RA-6	chr3:238139-238386	NONHSAT087559
18	lnc-CNTN6-7	chr3:239326-239775	NONHSAT087561
19	lnc-IL5RA-6	chr3:237441-237597	ENSG00000224318.1
20	lnc-CNTN6-7	chr3:238454-238746	NONHSAT087560

No data

Variant related genes	Relation type
CHL1	TF binding region
CHL1-AS2	TF binding region
CHL1	CpG island
CHL1-AS2	CpG island

Extended variants
information (count: 2911 )
Associated
traits (count: 87 )

Variant overlapped rSNPs/rCNVs (count:2911 , 50 per page) page: 1 2 3 4 5 6 7 ... 59

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs116431057	chr3:189814-189815	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs184536868	chr3:189819-189820	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs553177931	chr3:189863-189864	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs544995224	chr3:189914-189915	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs561620734	chr3:189947-189948	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs370956817	chr3:189955-189956	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs573643294	chr3:189994-189995	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs543866306	chr3:189995-189996	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs562473133	chr3:190004-190005	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs568215582	chr3:190028-190029	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs115254867	chr3:190030-190031	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs115817282	chr3:190045-190046	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs547154906	chr3:190053-190054	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs568465550	chr3:190062-190063	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs535917310	chr3:190067-190068	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs550714074	chr3:190069-190070	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs556501592	chr3:190075-190076	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs35400618	chr3:190148-190149	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs17038327	chr3:190200-190201	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs371520362	chr3:190208-190209	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs558029768	chr3:190210-190211	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs573143674	chr3:190221-190222	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs12496880	chr3:190222-190223	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs555880503	chr3:190224-190225	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs573675049	chr3:190241-190242	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs9757900	chr3:190250-190251	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs142887167	chr3:190267-190268	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs9754850	chr3:190290-190291	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs545368029	chr3:190294-190295	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs144964205	chr3:190304-190305	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs527541680	chr3:190305-190306	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs562311722	chr3:190308-190309	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs548928718	chr3:190344-190345	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs561103444	chr3:190368-190369	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs529404056	chr3:190382-190383	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs138750460	chr3:190396-190397	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs565150256	chr3:190402-190403	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs9754552	chr3:190411-190412	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs149534012	chr3:190440-190441	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs144097548	chr3:190448-190449	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs189748802	chr3:190453-190454	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs562843231	chr3:190500-190501	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs28754493	chr3:190574-190575	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs113903968	chr3:190685-190686	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs567830334	chr3:190709-190710	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs35835286	chr3:190740-190741	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs556220142	chr3:190795-190796	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs142789495	chr3:190853-190854	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs181399030	chr3:190873-190874	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs373605361	chr3:190881-190882	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:87)

Disease	PMID	Source
Cancer	20164920	CNVD
Lung cancer	16618734	CNVD
Autism	18349135	CNVD
Breast cancer	20409316	CNVD
Myelofibrosis	22110671	CNVD
Autism	22241247	CNVD
Intellectual disability	22045946	CNVD
Squamous cell cancer	19607727	CNVD
Gastric adenocarcinoma	19115996	CNVD
sporadic birth defects	19047251	CNVD
Mental retardation	17124404	CNVD
abnormal development	18461090	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Sudden cardiac death	19188705	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Ovarian cancer	21720365	CNVD
Neuroblastoma	18923191	CNVD
Papillary thyroid carcinoma	21436994	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Breast cancer	17603634	CNVD
Neuroblastoma	17327916	CNVD
Glioblastoma multiforme	21080181	CNVD
Colorectal cancer	21297112	CNVD
Lynch syndrome	18415027	CNVD
Renal cell carcinoma	18592004	CNVD
Acute myeloid leukemia	20729466	CNVD
Urothelial carcinoma	18382360	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	20967226	CNVD
Autism	22543975	CNVD
Attention deficit hyperactivity disorder	19546859	CNVD
lymphocytic leukemia	21291569	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	17289997	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Tetralogy of Fallot	22912587	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	20685689	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Thoracic aortic aneurysm	21092924	CNVD

Chromatin state (count:480 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:189800-190200	Enhancers	Brain Germinal Matrix	brain
2	chr3:189800-193200	Weak transcription	Ovary	ovary
3	chr3:193200-193600	Enhancers	Primary B cells from peripheral blood	blood
4	chr3:193200-193600	Enhancers	Ovary	ovary
5	chr3:197000-198000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
6	chr3:197600-198200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
7	chr3:201000-203000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
8	chr3:201200-201600	Enhancers	Primary hematopoietic stem cells	blood
9	chr3:201400-202800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
10	chr3:202600-202800	Enhancers	Primary hematopoietic stem cells	blood
11	chr3:204400-204600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
12	chr3:205600-206000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
13	chr3:205600-206800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
14	chr3:205800-206000	Enhancers	Brain Substantia Nigra	brain
15	chr3:206000-206200	Enhancers	Fetal Brain Female	brain
16	chr3:206000-207200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
17	chr3:206000-207600	Weak transcription	Brain Substantia Nigra	brain
18	chr3:206000-209000	Enhancers	Cortex derived primary cultured neurospheres	brain
19	chr3:206200-207200	Weak transcription	Fetal Brain Female	brain
20	chr3:206400-209000	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
21	chr3:206400-209000	Enhancers	Brain Germinal Matrix	brain
22	chr3:206600-209200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
23	chr3:206800-207200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
24	chr3:207200-207800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
25	chr3:207200-207800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
26	chr3:207200-208400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
27	chr3:207200-209000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
28	chr3:207200-209000	Enhancers	Fetal Brain Female	brain
29	chr3:207400-207800	Enhancers	Brain Angular Gyrus	brain
30	chr3:207400-208000	Enhancers	Brain Cingulate Gyrus	brain
31	chr3:207600-207800	Enhancers	Brain Hippocampus Middle	brain
32	chr3:207600-208000	Enhancers	Brain Anterior Caudate	brain
33	chr3:207600-208000	Enhancers	Brain Substantia Nigra	brain
34	chr3:207800-209000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
35	chr3:207800-215200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
36	chr3:209000-209200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
37	chr3:215200-215400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
38	chr3:215400-215600	Enhancers	Adipose Nuclei	Adipose
39	chr3:215400-215600	Enhancers	GM12878-XiMat	blood
40	chr3:215400-215800	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
41	chr3:215400-215800	Active TSS	Brain Anterior Caudate	brain
42	chr3:215400-216000	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
43	chr3:215400-216000	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
44	chr3:215400-216200	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
45	chr3:215600-215800	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Female	--
46	chr3:215600-215800	Flanking Active TSS	Liver	Liver
47	chr3:215600-216000	Enhancers	Breast Myoepithelial Primary Cells	Breast
48	chr3:215600-216000	Flanking Active TSS	Adipose Nuclei	Adipose
49	chr3:215600-216000	Flanking Active TSS	GM12878-XiMat	blood
50	chr3:215600-216200	Active TSS	Pancreatic Islets	Pancreatic Islet

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links